Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that members of its ...

Treatment with cyclosporine A 0.1% can reduce ocular surface temperature in patients with dry eye disease and meibomian gland dysfunction.

The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...

We often ignore the signs of eye issues, but we must pay attention to every part of our body, especially our eyes. In this ...

Barcelona and Inter Milan put on a show heading in the first leg with a eye toward advancing to the Champions League final.

Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to ...

Starting in 2025, the Eylea franchise as a whole began to decline due to competitive pressure from long-acting Vabysmo, which competes with Eylea HD, and Pabvlu, a biosimilar version of the original ...

Paris Saint-Germain came out victorious in the first leg of their Champions League semifinal against Arsenal, exiting North ...

Mike Fazio, director of value-based care at Navista, Cardinal Health, discusses a trending topic at the 2025 Community ...

CG Oncology, Inc. (CGON) shares ended the last trading session 25% higher at $27.97. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

European stocks opened higher on Tuesday, with results out from HSBC, Lufthansa, Volvo Cars, Adidas, BP, AstraZeneca, ...